Users Online Now:
840
(
Who's On?
)
Visitors Today:
74,446
Pageviews Today:
142,330
Threads Today:
61
Posts Today:
1,316
02:51 AM
Directory
Adv. Search
Topics
Forum
Back to Forum
Back to Thread
REPLY TO THREAD
Subject
Novavax up +6% As Its COVID-19 Vaccine Is Found 90% Effective, To Seek FDA OK
User Name
Font color:
Default
Dark Red
Red
Orange
Brown
Yellow
Green
Olive
Cyan
Blue
Dark Blue
Indigo
Violet
Black
Font:
Default
Verdana
Tahoma
Ms Sans Serif
In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.
[quote:DeploraVision ™:MV80ODE2MTg2XzUzQ0RCNTVB] Novavax (NASDAQ:NVAX) shares rose more than 6% in Monday’s premarket trading after the company said a phase-three trial had found its two-dose COVID-19 vaccine to be 90.4% effective. The trial had 29,960 participants across the U.S. and Mexico. The vaccine was found to be 100% effective in preventing moderate and severe infections and 93% effective against some variants, Novavax said. (NVAX to file for FDA approval in Q3) https://finance.yahoo.com/news/novavax-soars-covid-19-vaccine-063438092.html [/quote]
Original Message
Novavax (NASDAQ:NVAX) shares rose more than 6% in Monday’s premarket trading after the company said a phase-three trial had found its two-dose COVID-19 vaccine to be 90.4% effective.
The trial had 29,960 participants across the U.S. and Mexico.
The vaccine was found to be 100% effective in preventing moderate and severe infections and 93% effective against some variants, Novavax said.
(NVAX to file for FDA approval in Q3)
[
link to finance.yahoo.com (secure)
]
Pictures (click to insert)
General
Politics
Bananas
People
Potentially Offensive
Emotions
Big Round Smilies
Aliens and Space
Friendship & Love
Textual
Doom
Misc Small Smilies
Religion
Love
Random
View All Categories
|
Next Page >>